ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D11AH05 | BioTech | Dupilumab - 200mg | 10623 | 145720/1 | DUPIXENT | 200mg | 2 | Injectable solution | SC | Mersaco | Sanofi Winthrop Industrie | France | 123,001,362 L.L | 2.44 | E2 | Sanofi Aventis Groupe | France | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D11AH05 | BioTech | Dupilumab - 200mg | 11810 | 90923/1 | DUPIXENT | 200mg | 2 | Injectable solution | SC | Mersaco | Sanofi Winthrop Industrie | France | 123,001,362 L.L | 2.44 | E2 | Sanofi Winthrop Industrie | France | 12/12/20 | 0 |